The typical rash from a sulfa antibiotic is a maculopapular (morbilliform) eruption: flat and raised spots, a few millimetres across, symmetric, often merging into patches. It usually starts on the trunk and spreads outward, it usually itches, and it usually appears four to fourteen days into a first course — not within minutes. It is the single most common adverse reaction to sulfamethoxazole/trimethoprim.

Educational reference — not medical advice. This page describes what is generally known about a drug family. It cannot account for your history, your other medicines, or your circumstances. Decisions about your own treatment belong with your doctor or pharmacist.

What it looks like

A drug rash of this kind is described in textbooks as "morbilliform" — measles-like. Small flat spots (macules) and small raised spots (papules) appear together, densely enough that they often run into each other and form larger blotchy areas. The distribution is characteristically symmetric: both sides of the trunk, both arms, both legs. It commonly begins on the chest, back, or abdomen and moves outward toward the limbs over a day or two. Palms and soles are usually spared, though not always. Itch is common and can be substantial.

Skin tone changes what you see. On lighter skin the rash reads as pink or red. On brown and black skin the same eruption is frequently violaceous, dusky, greyish, or simply darker than surrounding skin rather than obviously red, and it can be considerably harder to see in poor lighting. Much of the standard description of drug rashes was written from lighter skin, which contributes to delayed recognition. Feeling for the raised, slightly warm texture of the papules, and checking under good light, matters more when redness is not the visible sign.

A sulfa rash is not the same as photosensitivity, which is also common with these drugs. Photosensitivity looks like an exaggerated sunburn, confined to sun-exposed skin — face, the V of the neck, forearms, backs of the hands — with a sharp cut-off at clothing lines. If the rash stops where the sleeve starts, that is a sun reaction rather than a generalised drug eruption.

How quickly it appears

This is the question most often asked, and the answer surprises people: the common sulfa rash is delayed. It is a T-cell mediated reaction, and T-cell responses take days to build. In someone taking a sulfa antibiotic for the first time, the rash typically emerges somewhere between day four and day fourteen — frequently at the point where the course is finishing or already finished. A rash appearing on day nine of a ten-day course is entirely characteristic, not evidence that something else caused it.

Immediate reactions do exist and behave completely differently. True IgE-mediated allergy produces hives (urticaria) — raised, intensely itchy weals that move around, with individual spots lasting less than 24 hours before fading and appearing elsewhere — typically within minutes to an hour of a dose. Hives, particularly with lip or tongue swelling, wheeze, or light-headedness, is a different and more urgent situation than a delayed maculopapular rash. More on the full range of symptoms.

On re-exposure, someone already sensitised can react much faster, sometimes within 24 to 48 hours. A rash that appears on day one of a repeat course, in someone who reacted before, is meaningful history.

The warning signs that change the picture

Most sulfa rashes are benign and settle on stopping the drug. A small number are the opening stage of something serious, and the distinction is made on the features below rather than on the rash alone.

Seek urgent medical assessment if any of these appear. Blisters, or skin that peels or sloughs. Sores or rawness in the mouth, eyes, or genitals. Skin that is painful or burning rather than itchy. A positive Nikolsky sign — skin that shears sideways under gentle pressure. Fever with the rash. Facial or eyelid swelling. Swollen lymph nodes. Feeling systemically unwell. Target-shaped lesions. Any of these can indicate Stevens-Johnson syndrome, toxic epidermal necrolysis, or DRESS, and these are time-critical.

Two patterns in particular are worth naming. SJS/TEN often begins with a prodrome of fever and malaise a day or two before the skin changes, then painful skin, mucosal involvement, and blistering. DRESS (drug reaction with eosinophilia and systemic symptoms) tends to arrive later — two to eight weeks in — with a widespread rash, facial swelling, fever, enlarged lymph nodes, and internal organ involvement that shows up on blood tests. Both are rare. Both are why "just a rash" is worth a look rather than a shrug when it comes with fever or mucosal symptoms. How mild and severe reactions are distinguished.

What to do about it

The decision to stop or continue a prescribed antibiotic belongs to the clinician who prescribed it, and this page cannot make it for you. What is worth knowing is what that conversation usually involves.

For an uncomplicated itchy maculopapular rash with no systemic features, stopping the drug is the usual step, and the rash then fades over one to two weeks. Antihistamines and emollients are commonly used for the itch; topical steroids are sometimes added. The rash frequently gets slightly worse for a day or two after stopping before it improves, which is expected and not a sign the diagnosis is wrong.

For any rash with the warning features above, the drug is stopped and the patient assessed promptly — the same day.

The part patients can control is the record. Write down the drug name, the date, what the rash looked like, where it started, what day of the course it appeared, whether there was fever or mouth involvement, and what treatment was needed. That description is what determines, years later, whether you are offered a sulfa drug again or steered to a second-line alternative for the rest of your life. "Rash on Bactrim, day 8, itchy, no fever, no mouth involvement, settled in ten days with antihistamines" is a genuinely useful record. "Sulfa — allergy" is not. What to tell your doctor.

Is a sulfa rash an allergy?

Sometimes, and the answer is less settled than the allergy label implies. A delayed maculopapular rash to an antibiotic is a genuine hypersensitivity reaction in many cases — T-cell mediated rather than IgE-mediated. But rashes appearing during a course of antibiotics have other causes too. Viral exanthems are common, and a person taking an antibiotic for an infection is by definition someone who was recently unwell. A proportion of childhood "antibiotic allergies" recorded on the strength of a rash turn out, on later assessment, to have been the virus rather than the drug.

This is why the label is worth revisiting rather than accepting permanently. There is no validated skin test for sulfonamide allergy, so where the question genuinely matters — a patient who needs TMP-SMX for PCP prophylaxis, for instance — the assessment is a careful history and, in selected patients under specialist supervision, a graded oral challenge. How sulfa allergy is tested and diagnosed, and why so many of these labels are wrong.

Rash from non-antibiotic sulfonamides

People who have had a rash on a sulfa antibiotic often ask whether the same will happen with furosemide, hydrochlorothiazide, or celecoxib. Generally not. Those drugs lack the N4 arylamine that drives sulfonamide hypersensitivity, and measured cross-reactivity rates are low. Where a patient with a past sulfa antibiotic rash does react to a later, unrelated drug, the most likely explanation is a general predisposition to drug reactions rather than a shared allergen. The evidence on cross-reactivity, and the full list of sulfa drugs sorted by whether they carry the arylamine.

Sulfa rash.